granted Robert P. Jornayvaz III, Executive Chairman of the Board and Chief Executive Officer of the Company, a temporary medical leave of absence, effective immediately
and Alexander J. Jessett from Executive Vice President-Chief Financial Officer to President and Chief Financial Officer.
Role change
(interim)
Llewellyn Farquharson
Chief Executive Officer
Zalatoris II Acquisition Corp
Effective
2024-03-15
Filed
April 17, 2024, 7:59 PM ET
On March 15, 2024, the Former Board appointed Llewellyn Farquharson, the then Chief Financial Officer of the Company, as Chief Executive Officer and director of the Company, in order to fill the vacancy created by the CEO Resignation (the “ Interim CEO Appointment ”).
Departed
Llewellyn Farquharson
Chief Executive Officer
Zalatoris II Acquisition Corp
Successor
Spyridon Bonatsos
Filed
April 17, 2024, 7:59 PM ET
On April 12, 2024, the board of directors (the “ Board ”) of the Company held a special meeting (the “ Meeting ”) during which the Board ratified Mr. Farquharson’s Termination and appointed Spyridon Bonatsos as Chief Executive Officer and director of the Company
Appointed
Spyridon Bonatsos
Chief Executive Officer
Zalatoris II Acquisition Corp
Effective
2024-04-12
Filed
April 17, 2024, 7:59 PM ET
the Board ratified Mr. Farquharson’s Termination and appointed Spyridon Bonatsos as Chief Executive Officer and director of the Company
Appointed
Henry Bruce
Chief Financial Officer
Zalatoris II Acquisition Corp
Effective
2024-03-15
Filed
April 17, 2024, 7:59 PM ET
Also on March 15, 2024, to fill the vacancy in the Former Board created by the Interim CEO Appointment, the Former Board appointed Henry Bruce as Chief Financial Officer and director of the Company.
Departed
Paul Davis
Chief Executive Officer
Zalatoris II Acquisition Corp
Filed
April 17, 2024, 7:59 PM ET
In early March of 2024, Paul Davis presented to the then current members of the board of directors (the “ Former Board ”) of Zalatoris II Acquisition Corp, a Nasdaq-listed exempted company formed in the Cayman Islands (the “ Company ”) a resignation letter resigning from his position as Chief Executive Officer and as a member of the Former Board (the “ CEO Resignation ”).
Departed
Paul Davis
Chief Executive Officer
Zalatoris Acquisition Corp.
Successor
Stephanos Papadopoulos
Filed
April 17, 2024, 7:59 PM ET
In early March of 2024, Paul Davis presented to the then current members of the board of directors (the “ Former Board ”) of Zalatoris Acquisition Corp., a Delaware corporation (the “ Company ”) a resignation letter resigning from his position as Chief Executive Officer and as a member of the Former Board
Appointed
Stephanos Papadopoulos
Chief Executive Officer
Zalatoris Acquisition Corp.
Effective
2024-03-15
Filed
April 17, 2024, 7:59 PM ET
On March 15, 2024, the Former Board appointed Stephanos Papadopoulos, a then independent director of the Company, as Chief Executive Officer and director of the Company, in order to fill the vacancy created by the CEO Resignation (the “ New CEO Appointment ”).
On April 17, 2024, Bloom Energy Corporation (the "Company" or "Bloom") issued a press release announcing that Daniel Berenbaum has been appointed to serve as the Company’s Chief Financial Officer effective as of April 29, 2024.
Appointed
Barbara Chan
principal financial officer and principal accounting officer
Omega Therapeutics, Inc.
Effective
2024-05-31
Filed
April 16, 2024, 7:59 PM ET
On April 16, 2024, the Board of Directors of the Company designated Barbara Chan, the Company’s Senior Vice President, Finance, as its principal financial officer and principal accounting officer, in each case effective on the Effective Date.
Departed
Joshua Reed
Chief Financial Officer
Omega Therapeutics, Inc.
Effective
2024-05-31
Successor
Barbara Chan
Filed
April 16, 2024, 7:59 PM ET
On April 10, 2024, Omega Therapeutics, Inc. (the “Company”) and Joshua Reed, the Company’s Chief Financial Officer, agreed to terminate his employment effective as of May 31, 2024
On April 16, 2024, Planet Fitness, Inc. (the “Company”) announced the appointment of Colleen Keating, age 55, as Chief Executive Officer (“CEO”) of the Company, effective June 10, 2024 ( the “Effective Date”).
The Board of Directors (the “Board”) of CareDx, Inc. (the “Company”) has appointed John W. Hanna as the Company’s President and Chief Executive Officer and as a Class III director of the Company, in each case effective April 15, 2024 (the “Effective Date”).
pursuant to which Dr. Forssell was discharged from his position as the Company’s President and CEO and will act as a Senior Advisor to the management team of NeoNode Technologies AB, the Company’s subsidiary, and the Board until December 31, 2024.
On April 16, 2024, James W. Tivy resigned from his position of Chief Financial Officer of M-tron Industries, Inc. ("M-tron", "MPTI", or the "Company"), effective immediately.
on April 16, 2024, the Board of Directors of the Company, by unanimous written consent, appointed Linda Biles, age 62, currently M-tron's Vice President and Controller, as Executive Vice President – Finance and as principal financial officer.
Departed
James W. Tivy
Chief Accounting Officer and principal financial officer
In connection with Mr. Humer’s appointment, Stephen DiPalma, the Company’s Interim Chief Financial Officer, principal financial officer and principal accounting officer, will cease to serve in such roles.
On April 16, 2024, Foghorn Therapeutics Inc. (the “Company”) announced that Kristian F. Humer had been appointed to serve as the Company’s Chief Financial Officer, effective immediately.
Role change
Mia L. DeMontigny
senior vice president, chief financial officer and treasurer
On April 1, 2024, William M. Schaefer was appointed as the Chief Financial Officer of Isabella Bank Corporation.
Role change
(interim)
Mark A. Skonieczny
Interim Chief Financial Officer
REV Group, Inc.
Effective
2024-04-15
Successor
Amy A. Campbell
Filed
April 15, 2024, 7:59 PM ET
Upon Ms. Campbell joining the Company on April 15, 2024, Mark A. Skonieczny, who had been serving as the Company’s Interim CFO, will step down as Interim CFO and continue in his role as President and Chief Executive Officer.
Appointed
Amy A. Campbell
Senior Vice President / Chief Financial Officer
REV Group, Inc.
Effective
2024-04-15
Filed
April 15, 2024, 7:59 PM ET
On April 15, 2024, the Board of Directors (the “Board”) of REV Group, Inc. (the “Company”) approved the appointment of Amy A. Campbell as Senior Vice President / Chief Financial Officer of the Company (“CFO”), effective as of April 15, 2024.
On April 15, 2024, the authorized members of the Board of Directors (the “Board”) of Sow Good Inc. (“Sow Good” or the “Company”) authorized and entered into an Employment Agreement dated April 15, 2024 with Brendon Fischer, the Company’s Interim Chief Financial Officer (“Employment Agreement”).
Departed
Andrew Birnbaum
Chief Executive Officer
Pedro's List, Inc.
Effective
2024-03-01
Successor
Dr. Abdul Saddiqui
Filed
April 15, 2024, 7:59 PM ET
On February 27, 2024, Mr. Andrew Birnbaum (“Mr.
Birnbaum”) informed Pedro’s List, Inc. (the “Company”) of his resignation from the positions of Chief Executive
Officer, President, Secretary, Chief Financial Officer, Treasurer, and Director of the Company effective March 1, 2024 (the “Effective
Date”).
Appointed
Dr. Abdul Saddiqui
Chief Executive Officer
Pedro's List, Inc.
Effective
2024-03-01
Filed
April 15, 2024, 7:59 PM ET
On the Effective Date, the Board has appointed Dr.
Abdul Saddiqui (“Dr. Saddiqui) , a current member the Company’s Board of Directors, as its Chief Executive Officer,
President, Chief Financial Officer, Treasurer, and Secretary and Dr. Saddiqui has agreed to such
appointments to become effective March 1, 2024 .
Appointed
Dr. Teddy Scott
President and Chief Executive Officer
Bakhu Holdings, Corp.
Effective
2024-04-10
Filed
April 15, 2024, 7:59 PM ET
On April 10, 2024, the Company appointed Dr. Teddy Scott as the President and Chief Executive Officer of the Company.
Mr. Hovsepian will succeed Jeffrey R. Tarr as principal executive officer, who will retire from the position of Chief Executive Officer effective as of April 16, 2024 (the “Transition Date”).
On April 9, 2024, the Board of Directors of Skillsoft Corp. (the “Company”) appointed Ronald W. Hovsepian as the Company’s Executive Chair and principal executive officer, effective as of April 16, 2024.
On April 11, 2024, the Board appointed Ryan Barretto, the Company’s current President, to succeed Mr. Howard as Chief Executive Officer effective as of the Effective Date.
Fu Wah resigned from his positions as the Chief Executive Officer, Chief Financial Officer, Secretary and Director of King Resources, Inc. (the “Company”).
Appointed
Wong Nga Yin Polin
Chief Executive Officer, Chief Financial Officer, Secretary and Director
Concurrently therewith, Wong Nga Yin Polin was appointed to serve as the new Chief Executive Officer, Chief Financial Officer, Secretary and Director of the Company.
On April 15, 2024, Envista Holdings Corporation (the “Company”) announced that it has appointed Paul Keel as the President and Chief Executive Officer of the Company, with such appointment to be effective as of May 1, 2024
On April 10, 2024 (the “Transition Date”), Microvast Holdings, Inc. (the “Company”) and Mr. Craig Webster, Chief Financial Officer, agreed that, effective as of the Transition Date, Mr. Webster would cease to be the Company’s Chief Financial Officer and would transition to the non-executive role of Special Advisor to the Company’s Chief Executive Officer.
On April 11, 2024, the Board of Directors, through a vote of Unanimous Written Consent appointed Mr. Ronald LoRicco, Sr, 59, to serve as the Acting Interim Chief Executive Officer.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.